Essential points for revisions in the guidelines of the JPS 7<sup>th</sup> edition and new resectability criteria in pancreatic cancer

DOI Web Site 4 References Open Access
  • YAMADA Suguru
    Nagoya University Graduate School of Medicine, Gastroenterological Surgery (Surgery II)
  • TAKANO Nao
    Nagoya University Graduate School of Medicine, Gastroenterological Surgery (Surgery II)
  • KODERA Yasuhiro
    Nagoya University Graduate School of Medicine, Gastroenterological Surgery (Surgery II)

Bibliographic Information

Other Title
  • 1．膵癌取扱い規約第7版における変更の要点と新たな切除可能性分類

Search this article

Description

<p>Resectability criteria for pancreatic cancer have been established by the NCCN guidelines and have been implemented in our clinics, however, these are revised annually and we address certain issues. The 7th edition of the JPS guidelines was published last year and the tumor extent (T), the lymph node metastasis (N) and stage classification were revised in order to maintain the compatibility with those of the 7th UICC guidelines. Also, new criteria for histological response and original resectability criteria for Japan are proposed. Based on these new resectability criteria, the survival outcomes in our resected pancreatic cancer patients without neoadjuvant therapy were analyzed. As a result, the definition of borderline resectable pancreatic cancer based on the degree of portal system invasion (abutment/contact) is shown to be valid. Compared to the NCCN guidelines, the new resectability criteria is written much more clearly and concisely, and is very useful for decision-making and use in clinical trials.</p>

Journal

  • Suizo

    Suizo 33 (1), 12-17, 2018

    Japan Pancreas Society

References(4)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top